MFOHome About Commentary Discussions Funds The Best Resources Support Us!

Howdy, Stranger!

It looks like you're new here. If you want to get involved, click one of these buttons!

Sign In Register

Categories

Here's a statement of the obvious: The opinions expressed here are those of the participants, not those of the Mutual Fund Observer. We cannot vouch for the accuracy or appropriateness of any of it, though we do encourage civility and good humor.

    Support MFO

  • Donate through PayPal

Biotech ETFs Go Under The Microscope: Video Presentation

TedTed
edited April 2018 in The Bullpen
FYI: Brad Loncar, Loncar Investments CEO, created the Loncar Cancer Immunotherapy Sector Index (LCINDX), which is tracked by the CNCR ETF, one of the year’s best-performing nonleveraged equity ETFs. Loncar talked with Bloomberg's Scarlet Fu and Eric Balchunas about CNCR and biotech ETFs.
Regards,
Ted
https://www.bloomberg.com/news/videos/2018-04-12/biotech-etfs-go-under-the-microscope-video

M* Snapshot CNCR:
http://www.morningstar.com/etfs/XNAS/CNCR/quote.html
Sign In or Register to comment.